News & Updates

IMBRUVICA™ Approved For Previously Treated Chronic Lymphocytic Leukemia; Immediately Available Through Onco360®
Press Releases published on February 12, 2014 in News & Updates
Onco360, the nation’s fastest-growing independent Oncology Pharmacy and Clinical Support Services company, is proud to be part of the limited Specialty Pharmacy Network of IMBRUVICA™(ibrutinib).
Read More
The Academy of Oncology Nurse & Patient Navigators (AONN+) Changes Its Name to Represent Commitment to Broader Membership
Press Releases published on December 5, 2013 in News & Updates
CRANBURY, NJ (December 5, 2013)—The Academy of Oncology Nurse Navigators, Inc.® (AONN) changed its name effective December 1, 2013, to the Academy of Oncology Nurse & Patient Navigators, Inc.® (AONN+). This change is part of a larger branding effort to emphasize the organization’s commitment to all those who are involved in navigation and survivorship care services.
Read More
Lillie Shockney, RN, BS, MAS, named as Program Director by the Academy of Oncology Nurse Navigators
Press Releases published on May 1, 2013 in News & Updates
The Academy of Oncology Nurse Navigators (AONN) is pleased to announce that Lillie Shockney, RN, BS, MAS, has been named as its Program Director. In this role, Ms. Shockney will be responsible for the day-to-day direction of the Association’s activities, as well as driving key initiatives to advance the Association’s mission.
Read More
Page 8 of 8
Results 71 - 73 of 73

Back to Top

 

ASSOCIATION

 

MEMBERSHIP

 
AONN

Privacy Notice   |   Terms of Use
© 2009- DBA AONN+ Academy of Oncology Nurse & Patient Navigators®   |   15 W 38th St. Ste 1209, New York, NY 10018-5501   |    This email address is being protected from spambots. You need JavaScript enabled to view it.
AONN+ DBA AONN+ is a 501(c)(6) organization under federal tax guidelines. AONN+ Foundation for Learning, Inc. a 501(c)(3) organization under federal tax guidelines.
AONN+ Advantage, LLC, a wholly owned subsidiary of AONN+.